TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+4.28%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$726M
AUM Growth
+$726M
(+2.6%)
Cap. Flow
+$23.2M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
40.72%
Holding
81
New
7
Increased
31
Reduced
27
Closed
3
Top Buys
| 1 |
Neogen
NEOG
|
$8.09M |
| 2 |
Brown-Forman Class B
BF.B
|
$5.21M |
| 3 |
United Parcel Service
UPS
|
$1.71M |
| 4 |
Starbucks
SBUX
|
$921K |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$803K |
Top Sells
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$1.87M |
| 2 |
Schlumberger
SLB
|
$1.5M |
| 3 |
Kimberly-Clark
KMB
|
$886K |
| 4 |
TIF
Tiffany & Co.
TIF
|
$760K |
| 5 |
Unilever
UL
|
$496K |
Sector Composition
| 1 | Healthcare | 44.52% |
| 2 | Technology | 11.82% |
| 3 | Industrials | 10.11% |
| 4 | Consumer Discretionary | 6.69% |
| 5 | Financials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cognex
CGNX
$7.43B
| $38.4M | 5.29% |
739,400
+6,915
| +0.9% | +$360K |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $33.4M | 4.6% |
342,336
-7,784
| -2% | -$760K |
|
|
3
Neogen
NEOG
$1.23B
| $30.7M | 4.23% |
458,846
+120,702
| +36% | +$8.09M |
|
4
Analog Devices
ADI
$122B
| $30.2M | 4.16% |
331,695
+3,424
| +1% | +$312K |
|
5
Idexx Laboratories
IDXX
$51.2B
| $29.3M | 4.04% |
153,230
-1,090
| -0.7% | -$209K |
|
|
RTN
6
DELISTED
Raytheon Company
RTN
| $28.8M | 3.96% |
133,322
+475
| +0.4% | +$103K |
|
7
Mastercard
MA
$535B
| $27.3M | 3.75% |
155,615
-335
| -0.2% | -$58.7K |
|
8
Insulet
PODD
$24.3B
| $26.3M | 3.62% |
303,040
+755
| +0.2% | +$65.4K |
|
|
9
Brown-Forman Class B
BF.B
$13.8B
| $26.1M | 3.59% |
479,536
+95,815
| +25% | +$5.21M |
|
10
Johnson & Johnson
JNJ
$429B
| $25.2M | 3.46% |
196,291
-1,048
| -0.5% | -$134K |
|
11
Danaher
DHR
$146B
| $24.2M | 3.33% |
246,735
+4,365
| +2% | +$427K |
|
|
ABMD
12
DELISTED
Abiomed Inc
ABMD
| $23.3M | 3.21% |
80,180
-455
| -0.6% | -$132K |
|
13
Honeywell
HON
$138B
| $22.9M | 3.16% |
158,667
+2,495
| +2% | +$361K |
|
14
DexCom
DXCM
$29.1B
| $21.5M | 2.96% |
289,829
+9,284
| +3% | +$689K |
|
15
Inogen
INGN
$219M
| $20.6M | 2.84% |
167,915
+3,860
| +2% | +$474K |
|
16
Novo Nordisk
NVO
$251B
| $20M | 2.75% |
405,995
-485
| -0.1% | -$23.9K |
|
17
Biogen
BIIB
$20.5B
| $19.8M | 2.72% |
72,227
-1,390
| -2% | -$381K |
|
|
18
Starbucks
SBUX
$102B
| $19.2M | 2.64% |
331,373
+15,903
| +5% | +$921K |
|
19
Ross Stores
ROST
$49.5B
| $17.2M | 2.37% |
220,983
+7,503
| +4% | +$585K |
|
|
NVRO
20
DELISTED
NEVRO CORP.
NVRO
| $14.6M | 2.01% |
168,805
+9,260
| +6% | +$803K |
|
21
Henry Schein
HSIC
$8.29B
| $13.2M | 1.82% |
197,063
-1,390
| -0.7% | -$93.4K |
|
22
Amgen
AMGN
$154B
| $13.1M | 1.81% |
77,024
-750
| -1% | -$128K |
|
23
Mettler-Toledo International
MTD
$26.3B
| $12.7M | 1.75% |
22,110
+1,325
| +6% | +$762K |
|
24
Dentsply Sirona
XRAY
$2.75B
| $12.6M | 1.74% |
250,918
+5,036
| +2% | +$253K |
|
25
AbbVie
ABBV
$374B
| $11.8M | 1.62% |
124,550
-1,300
| -1% | -$123K |
|